Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Comprehensive T cell repertoire characterization of non-small cell lung cancer

Open access

Abstract

Immunotherapy targeting T cells is increasingly utilized to treat solid tumors including non-small cell lung cancer (NSCLC). This requires a better understanding of the T cells in the lungs of patients with NSCLC. Here, we report T cell repertoire analysis in a cohort of 236 early-stage NSCLC patients. T cell repertoire attributes are associated with clinicopathologic features, mutational and immune landscape. A considerable proportion of the most prevalent T cells in tumors are also prevalent in the uninvolved tumor-adjacent lungs and appear specific to shared background mutations or viral infections. Patients with higher T cell repertoire homology between the tumor and uninvolved tumor-adjacent lung, suggesting a less tumor-focused T cell response, exhibit inferior survival. These findings indicate that a concise understanding of antigens and T cells in NSCLC is needed to improve therapeutic efficacy and reduce toxicity with immunotherapy, particularly adoptive T cell therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-14273-0

Cites

Statistics

Figures

Fig. 1 TCR clonality is associated with CD8 T cell function. Correlation between T cell clonality and (a) CD3 density (n = 135), (b) CD4 density (n = 135) and (c) CD8 density (n = 135) by IHC as well as (d) GzmB expression (n = 141), (e) IFN-γ expression (n = 141) by gene expression profiling.
Fig. 1 TCR clonality is associated with CD8 T cell function. Correlation between T cell clonality and (a) CD3 density (n = 135), (b) CD4 density (n = 135) and (c) CD8 density (n = 135) by IHC as well as (d) GzmB expression (n = 141), (e) IFN-γ expression (n = 141) by gene expression profiling.CC BY · PubMed Central
Fig. 2 T cell density, richness and clonality are enriched in PD-1hi tumors. (a) T cell density (n = 135), (b) richness (n = 134) and (c) clonality (n = 135) in CD45ROhi and CD45ROlo tumors. (d) T cell density (n = 135), (e) richness (n = 134) and (f) clonality (n = 135) in PD-1hi and PD-1lo tumors. Bars represent median and quartiles.
Fig. 2 T cell density, richness and clonality are enriched in PD-1hi tumors. (a) T cell density (n = 135), (b) richness (n = 134) and (c) clonality (n = 135) in CD45ROhi and CD45ROlo tumors. (d) T cell density (n = 135), (e) richness (n = 134) and (f) clonality (n = 135) in PD-1hi and PD-1lo tumors. Bars represent median and quartiles.CC BY · PubMed Central
Fig. 3 T cell clonality is lower in EGFR mutant tumors. a Correlation between tumor mutational burden (n = 215) by whole exome sequencing and clonality. b Tumor mutational burden (n = 186), (c) T cell density (n = 186), (d) richness (n = 186) and (e) clonality (n = 186) in EGFR wildtype (white) and mutant (red) tumors. f Tumor mutational burden (n = 51), (g) T cell density (n = 43), (h) richness (n = 43) and (i) clonality (n = 43) in EGFR wildtype (white) and mutant (red) tumors when analyzing only tumors with a low (bottom tertile) TMB. Bars represent median and quartiles.
Fig. 3 T cell clonality is lower in EGFR mutant tumors. a Correlation between tumor mutational burden (n = 215) by whole exome sequencing and clonality. b Tumor mutational burden (n = 186), (c) T cell density (n = 186), (d) richness (n = 186) and (e) clonality (n = 186) in EGFR wildtype (white) and mutant (red) tumors. f Tumor mutational burden (n = 51), (g) T cell density (n = 43), (h) richness (n = 43) and (i) clonality (n = 43) in EGFR wildtype (white) and mutant (red) tumors when analyzing only tumors with a low (bottom tertile) TMB. Bars represent median and quartiles.CC BY · PubMed Central
Fig. 4 The T cell repertoire is associated to clinicopathologic attributes. a T cell density in adenocarcinomas (n = 135) and squamous cell carcinomas (n = 89). (b) T cell richness in adenocarcinomas (n = 134) and squamous cell carcinomas (n = 89). c Correlation between T cell density or (d) richness and tumor size (n = 225). e T cell clonality in current (n = 101), former (n = 107), and never smokers (n = 16). f T cell richness in relapsed (n = 70) versus non-relapsed (n = 64) adenocarcinoma patients. Bars represent median and quartiles.
Fig. 4 The T cell repertoire is associated to clinicopathologic attributes. a T cell density in adenocarcinomas (n = 135) and squamous cell carcinomas (n = 89). (b) T cell richness in adenocarcinomas (n = 134) and squamous cell carcinomas (n = 89). c Correlation between T cell density or (d) richness and tumor size (n = 225). e T cell clonality in current (n = 101), former (n = 107), and never smokers (n = 16). f T cell richness in relapsed (n = 70) versus non-relapsed (n = 64) adenocarcinoma patients. Bars represent median and quartiles.CC BY · PubMed Central
Fig. 5 T cell clonality is increased in the tumor-adjacent lung. a T cell density, (b) richness, and (c) clonality in the peripheral blood (green, n = 121), uninvolved tumor-adjacent lung (blue, n = 216) and tumor (red, n = 225). d T cell density (n = 253), (e) richness (n = 253), and f clonality (n = 253) in healthy (white), COPD (light blue), and tumor-adjacent uninvolved lungs (blue) from smokers and non-smokers. Bars represent median and quartiles.
Fig. 5 T cell clonality is increased in the tumor-adjacent lung. a T cell density, (b) richness, and (c) clonality in the peripheral blood (green, n = 121), uninvolved tumor-adjacent lung (blue, n = 216) and tumor (red, n = 225). d T cell density (n = 253), (e) richness (n = 253), and f clonality (n = 253) in healthy (white), COPD (light blue), and tumor-adjacent uninvolved lungs (blue) from smokers and non-smokers. Bars represent median and quartiles.CC BY · PubMed Central
Fig. 6 T cell repertoire overlap between adjacent uninvolved lung and tumor. a Jaccard Index when comparing PBMC, uninvolved tumor-adjacent lung, and tumor T cell repertoires (n = 215). b Proportion of the top 100 T cells in the tumor shared with the uninvolved tumor-adjacent lung (n = 225). c Jaccard Index in the T cell repertoire when comparing the tumor-adjacent uninvolved lung to tumors, lung-enriched (e) T cell repertoire between the tumor-adjacent uninvolved lung and tumor, and different regions of the same tumor (ITH) (n = 215). Bars represent median and quartiles.
Fig. 6 T cell repertoire overlap between adjacent uninvolved lung and tumor. a Jaccard Index when comparing PBMC, uninvolved tumor-adjacent lung, and tumor T cell repertoires (n = 215). b Proportion of the top 100 T cells in the tumor shared with the uninvolved tumor-adjacent lung (n = 225). c Jaccard Index in the T cell repertoire when comparing the tumor-adjacent uninvolved lung to tumors, lung-enriched (e) T cell repertoire between the tumor-adjacent uninvolved lung and tumor, and different regions of the same tumor (ITH) (n = 215). Bars represent median and quartiles.CC BY · PubMed Central
Fig. 7 Some mutations are shared between the tumor and adjacent uninvolved lung. a Tumor mutational burden in patients with NSCLC (n = 96). b Mutational burden in the tumor-adjacent uninvolved lung (n = 96). c Number of mutations shared between the tumor and tumor-adjacent uninvolved lung (n = 96). d–e Proportion of mutations found exclusively in the tumor (red), in the tumor-adjacent uninvolved lung (blue), or shared (purple) (n = 96).
Fig. 7 Some mutations are shared between the tumor and adjacent uninvolved lung. a Tumor mutational burden in patients with NSCLC (n = 96). b Mutational burden in the tumor-adjacent uninvolved lung (n = 96). c Number of mutations shared between the tumor and tumor-adjacent uninvolved lung (n = 96). d–e Proportion of mutations found exclusively in the tumor (red), in the tumor-adjacent uninvolved lung (blue), or shared (purple) (n = 96).CC BY · PubMed Central
Fig. 8 Shared T cells may target shared mutations and viruses. a Correlation between the proportion of shared mutations (NSEM) and shared top 100 T cells between the uninvolved tumor-adjacent lung and tumor (n = 92). b–c Fold difference between non-viral and viral T cell motifs found exclusively in the tumor-adjacent uninvolved lung (blue), tumor (red), or shared (n = 178). d Proportion of patients with viral (solid) or non-viral (white) motifs enriched in the uninvolved tumor-adjacent lung (blue), tumor (red), or shared T cells (purple) (n = 178). e Proportion of non-viral (n = 215) and (f) viral motifs (n = 215) in healthy, COPD, or tumor-adjacent uninvolved lungs. Bars represent median and quartiles.
Fig. 8 Shared T cells may target shared mutations and viruses. a Correlation between the proportion of shared mutations (NSEM) and shared top 100 T cells between the uninvolved tumor-adjacent lung and tumor (n = 92). b–c Fold difference between non-viral and viral T cell motifs found exclusively in the tumor-adjacent uninvolved lung (blue), tumor (red), or shared (n = 178). d Proportion of patients with viral (solid) or non-viral (white) motifs enriched in the uninvolved tumor-adjacent lung (blue), tumor (red), or shared T cells (purple) (n = 178). e Proportion of non-viral (n = 215) and (f) viral motifs (n = 215) in healthy, COPD, or tumor-adjacent uninvolved lungs. Bars represent median and quartiles.CC BY · PubMed Central
Fig. 9 A more tumor-focused lung T cell repertoire is associated with improved overall survival (OS). a Association between high (red) and low (blue) T cell density in PBMC and OS (n = 120). b Association between high (red) and low (blue) T cell density in the uninvolved tumor-adjacent lung and OS (n = 216). c Association between high (red) and low (blue) T cell clonality in the uninvolved tumor-adjacent lung (enriched compared to the tumor) and OS (n = 214). d Association between high (red) and low (blue) T cell density in PBMC and lung cancer-specific survival (n = 90). e Association between high (red) and low (blue) T cell density in the uninvolved tumor-adjacent lung and lung cancer-specific survival (n = 157). f Association between high (red) and low (blue) T cell clonality in the uninvolved tumor-adjacent lung (enriched compared to the tumor) and lung cancer-specific survival (n = 156). High, above median; Low, below median.
Fig. 9 A more tumor-focused lung T cell repertoire is associated with improved overall survival (OS). a Association between high (red) and low (blue) T cell density in PBMC and OS (n = 120). b Association between high (red) and low (blue) T cell density in the uninvolved tumor-adjacent lung and OS (n = 216). c Association between high (red) and low (blue) T cell clonality in the uninvolved tumor-adjacent lung (enriched compared to the tumor) and OS (n = 214). d Association between high (red) and low (blue) T cell density in PBMC and lung cancer-specific survival (n = 90). e Association between high (red) and low (blue) T cell density in the uninvolved tumor-adjacent lung and lung cancer-specific survival (n = 157). f Association between high (red) and low (blue) T cell clonality in the uninvolved tumor-adjacent lung (enriched compared to the tumor) and lung cancer-specific survival (n = 156). High, above median; Low, below median.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 55 · Cited by 220

Metadata

Authors
Reuben, A., Zhang, J., Chiou, S.-H., Gittelman, R. M., Li, J., Lee, W.-C., Fujimoto, J., Behrens, C., Liu, X., Wang, F., Quek, K., Wang, C., Kheradmand, F., Chen, R., Chow, C.-W., Lin, H., Bernatchez, C., Jalali, A., Hu, X., Wu, C.-J., Eterovic, A. K., Parra, E. R., Yusko, E., Emerson, R., Benzeno, S., Vignali, M., Wu, X., Ye, Y., Little, L. D., Gumbs, C., Mao, X., Song, X., Tippen, S., Thornton, R. L., Cascone, T., Snyder, A., Wargo, J. A., Herbst, R., Swisher, S., Kadara, H., Moran, C., Kalhor, N., Zhang, J., Scheet, P., Vaporciyan, A. A., Sepesi, B., Gibbons, D. L., Robins, H., Hwu, P., Heymach, J. V., Sharma, P., Allison, J. P., Baladandayuthapani, V., Lee, J. J., Davis, M. M., Wistuba, I. I., Futreal, P. A., & Zhang, J.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Howard Hughes Medical Institute (US)
  • Adaptive Biotechnologies (United States) (US)
  • iRepertoire (United States) (US)
  • Baylor College of Medicine (US)
  • Yale Cancer Center (US)
  • Fred Hutch Cancer Center (US)
Corresponding author
  • Zhang, Jiexin
  • Zhang, Jianhua
  • Davis, Mark M.
  • Wistuba, Ignacio I.
  • Futreal, P. Andrew
  • Zhang, Jianjun
Venue
Nature Communications
Published
2020-01-30
Volume
11
Issue
1
Pages
603-603
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3003556485
Cited by
220
References
55
Citations by year
2026: 17 · 2025: 26 · 2024: 35 · 2023: 35 · 2022: 39 · 2021: 42 · 2020: 26
FWCI
13.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Welch Foundation
  • Howard Hughes Medical Institute
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
non-small cell lung cancer, T cell receptor repertoire, tumor-infiltrating T cells, viral infection, immune landscape, mutational landscape, adoptive T cell therapy, immunotherapy, survival
MeSH terms
Adult, Aged, Carcinoma, Non-Small-Cell Lung, Clone Cells, Female, Humans, Lung, Lung Neoplasms, Lymphocyte Activation, Male, Middle Aged, Mutation, T-Lymphocytes, Survival Analysis, Lymphocyte Count, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive T cell repertoire characterization of non-small cell lung cancer. https://app.cochat.ai/papers/10.1038/s41467-019-14273-0
The paper
Reuben, A., Zhang, J., Chiou, S.-H., Gittelman, R. M., Li, J., Lee, W.-C., Fujimoto, J., Behrens, C., Liu, X., Wang, F., Quek, K., Wang, C., Kheradmand, F., Chen, R., Chow, C.-W., Lin, H., Bernatchez, C., Jalali, A., Hu, X., . . . Zhang, J. (2020). Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nature Communications. https://doi.org/10.1038/s41467-019-14273-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.